Mili is a technology platform that enables the collection of speech data from participants in clinical studies and trials through multiple frontends. It integrates existing speech biomarkers and machine learning models that can be automatically applied to the collected speech data. Studies can be planned, managed and monitored by sites/sponsors through a web interface.
Mili phone is a patient-facing frontend that does not require any setup or installation from the participant. It is no device, no app, no tool – it’s a simple phone call.Mili will reach out to study participants by calling them & guiding them fully automatically trough a phone call while collecting their speech.
Listen to an example phone call for a MCI screening in a fully integrated setting (Mili integrated into study registration frontend) by clicking on the video.
Mili App is the App frontend that can be used in in-clinic settings or by patients on their own mobile devices at home. It is design with participants in mind keeping it as intuitive and easy to use as possible.
View an example Mili App assessment for a MCI screening and get an idea about the app.
Validated speech biomarkers and predictive models can be integrated into Mili to enable a number of different use cases in one single platform, e.g. to (pre-)screen for MCI or to measure cognition with biomarker as an endpoint.
Mili and all integrated ki:elements components are developed under our internal quality management system, following guidelines & principles GDPR, ISO 13485:2016, FDA 21 CFR part 11 & part 820.70 and computer system validation (CSV).
Mili is fit for purpose to be used in highly regulated environments, like clinical drug trials.
Your message (optional)
I agree that my details from the contact form are collected and processed to answer my enquiry. The data will be stored for 10 years or deleted upon request.
Note: You can revoke your consent for the future at any time by sending an email to [email protected]. Detailed information on the handling of user data can be found in our data protection statement.